Cellular fibronectin promotes deep vein thrombosis in diet-induced obese mice.
NETosis
deep vein thrombosis
diet-induced obesity
fibronectin
Journal
Journal of thrombosis and haemostasis : JTH
ISSN: 1538-7836
Titre abrégé: J Thromb Haemost
Pays: England
ID NLM: 101170508
Informations de publication
Date de publication:
03 2021
03 2021
Historique:
received:
22
09
2020
revised:
02
11
2020
accepted:
04
12
2020
pubmed:
11
12
2020
medline:
15
5
2021
entrez:
10
12
2020
Statut:
ppublish
Résumé
Overweight and obesity are significant risk factors for deep vein thrombosis (DVT). Cellular fibronectin containing extra domain A (Fn-EDA), an endogenous ligand for toll-like-receptor 4 (TLR4), contributes to thrombo-inflammation. The role of Fn-EDA in the modulation of DVT is not elucidated yet. To determine whether Fn-EDA promotes DVT in the context of diet-induced obesity. Wild-type (WT) and Fn-EDA-deficient mice were either fed control or high-fat (HF) diet for 12 weeks. DVT was induced by inferior vena cava (IVC) stenosis and evaluated after 48 hours. Cellular Fn-EDA levels in the plasma of venous thromboembolism (VTE) patients were measured by sandwich ELISA. We found that cellular Fn-EDA levels were significantly elevated in VTE patients' plasma and positively correlated with body mass index. HF diet-fed WT mice exhibited increased DVT susceptibility compared with control diet-fed WT mice. In contrast, HF diet-fed Fn-EDA-deficient mice exhibited significantly reduced thrombus weight and decreased incidence (%) of DVT compared with HF diet-fed WT mice concomitant with reduced neutrophil content and citrullinated histone H3-positive cells (a marker of NETosis) in IVC thrombus. Exogenous cellular Fn-EDA potentiated NETosis in neutrophils stimulated with thrombin-activated platelets via TLR4. Genetic deletion of TLR4 in Fn-EDA These results demonstrate a previously unknown role of Fn-EDA in the DVT exacerbation, which may be an essential mechanism promoting DVT in the setting of diet-induced obesity.
Sections du résumé
BACKGROUND
Overweight and obesity are significant risk factors for deep vein thrombosis (DVT). Cellular fibronectin containing extra domain A (Fn-EDA), an endogenous ligand for toll-like-receptor 4 (TLR4), contributes to thrombo-inflammation. The role of Fn-EDA in the modulation of DVT is not elucidated yet.
OBJECTIVE
To determine whether Fn-EDA promotes DVT in the context of diet-induced obesity.
METHODS
Wild-type (WT) and Fn-EDA-deficient mice were either fed control or high-fat (HF) diet for 12 weeks. DVT was induced by inferior vena cava (IVC) stenosis and evaluated after 48 hours. Cellular Fn-EDA levels in the plasma of venous thromboembolism (VTE) patients were measured by sandwich ELISA.
RESULTS
We found that cellular Fn-EDA levels were significantly elevated in VTE patients' plasma and positively correlated with body mass index. HF diet-fed WT mice exhibited increased DVT susceptibility compared with control diet-fed WT mice. In contrast, HF diet-fed Fn-EDA-deficient mice exhibited significantly reduced thrombus weight and decreased incidence (%) of DVT compared with HF diet-fed WT mice concomitant with reduced neutrophil content and citrullinated histone H3-positive cells (a marker of NETosis) in IVC thrombus. Exogenous cellular Fn-EDA potentiated NETosis in neutrophils stimulated with thrombin-activated platelets via TLR4. Genetic deletion of TLR4 in Fn-EDA
CONCLUSION
These results demonstrate a previously unknown role of Fn-EDA in the DVT exacerbation, which may be an essential mechanism promoting DVT in the setting of diet-induced obesity.
Identifiants
pubmed: 33300307
doi: 10.1111/jth.15206
pmc: PMC8527852
mid: NIHMS1746125
pii: S1538-7836(22)00689-4
doi:
Substances chimiques
Fibronectins
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
814-821Subventions
Organisme : NIH HHS
ID : R01NS109910
Pays : United States
Organisme : NIH HHS
ID : U01NS113388
Pays : United States
Organisme : NHLBI NIH HHS
ID : R35 HL139926
Pays : United States
Organisme : NINDS NIH HHS
ID : U01 NS113388
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL118246
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL118742
Pays : United States
Organisme : NIH HHS
ID : R35 HL139926
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS109910
Pays : United States
Informations de copyright
© 2020 International Society on Thrombosis and Haemostasis.
Références
J Lab Clin Med. 1989 May;113(5):586-97
pubmed: 2715681
Immunology. 1991 Sep;74(1):114-20
pubmed: 1937565
Obes Rev. 2002 May;3(2):85-101
pubmed: 12120424
Oncotarget. 2015 Aug 14;6(23):19350-1
pubmed: 26305982
Thromb Haemost. 2015 Jan;113(1):85-96
pubmed: 25318550
Thromb Res. 2008;122(4):549-55
pubmed: 18234295
Exp Mol Pathol. 1988 Jun;48(3):403-18
pubmed: 3371462
Acta Med Scand. 1987;222(3):275-9
pubmed: 3321923
Arterioscler Thromb Vasc Biol. 2008 Feb;28(2):296-301
pubmed: 17991876
Inflammation. 2016 Jun;39(3):1059-68
pubmed: 27022744
PLoS One. 2012;7(7):e41254
pubmed: 22911769
Sci Transl Med. 2014 Apr 16;6(232):232ra50
pubmed: 24739758
Thromb Haemost. 2017 Jan 26;117(2):339-348
pubmed: 27975098
Thromb Haemost. 2018 Aug;118(8):1450-1460
pubmed: 29960272
Int Wound J. 2018 Aug;15(4):649-659
pubmed: 29536628
Arterioscler Thromb Vasc Biol. 2013 Jan;33(1):147-51
pubmed: 23104849
Diabetes Care. 2001 Feb;24(2):323-7
pubmed: 11213886
Blood. 2015 May 14;125(20):3164-72
pubmed: 25700433
Stroke. 2019 May;50(5):1201-1209
pubmed: 30909835
PLoS One. 2013 May 31;8(5):e65061
pubmed: 23741455
Arterioscler Thromb Vasc Biol. 2018 Mar;38(3):500-508
pubmed: 29326316
J Exp Med. 2012 Apr 9;209(4):819-35
pubmed: 22451716
J Cell Biol. 2003 Jul 7;162(1):149-60
pubmed: 12847088
Trends Immunol. 2018 Aug;39(8):610-623
pubmed: 29776849
Thromb Res. 2018 Oct;170:87-96
pubmed: 30138777
Open J Prev Med. 2012 Nov;2(4):499-509
pubmed: 26236563
J Clin Invest. 2014 Oct;124(10):4281-93
pubmed: 25180602
Circulation. 2015 Dec 8;132(23):2237-47
pubmed: 26508731
J Thromb Haemost. 2013 Jun;11 Suppl 1:233-41
pubmed: 23809127
J Vis Exp. 2017 Dec 22;(130):
pubmed: 29286428
Curr Opin Hematol. 2013 Sep;20(5):437-44
pubmed: 23817170
Am J Med. 2005 Sep;118(9):978-80
pubmed: 16164883
J Intern Med. 2015 May;277(5):573-84
pubmed: 25161014
Obes Res. 2003 Nov;11(11):1278-89
pubmed: 14627747
Methods Mol Biol. 2012;821:421-33
pubmed: 22125082
Arterioscler Thromb Vasc Biol. 2012 Aug;32(8):1777-83
pubmed: 22652600
Circ Res. 2020 Jun 5;126(12):1779-1794
pubmed: 32195632
J Biol Chem. 2001 Mar 30;276(13):10229-33
pubmed: 11150311
J Vasc Surg. 2008 Dec;48(6):1575-84
pubmed: 18829216